Autolus

Reflecting Stevenage’s architectural character, the Autolus facility features a structured grid façade, balancing functionality with visual interest. A mix of metal panels and glazed bays adds depth, while an articulated ground floor enhances the building’s street presence. The façade’s upper framework conceals rooftop plant, maintaining clean sightlines. Landscaped green spaces and permeable paving enhance the public realm, creating a thoughtful transition between the facility and the surrounding town centre.

Located in Stevenage’s life sciences cluster, one of Europe’s largest biotech hubs, Autolus is positioned at the centre of the UK’s rapidly growing cell and gene therapy ecosystem. With direct access to a network of leading research institutions, biotech companies, and advanced manufacturing facilities, the site benefits from strong transport links and a strategic location within the Golden Triangle of London, Oxford, and Cambridge. This state-of-the-art facility reinforces Stevenage’s status as a global destination for scientific innovation and investment.

The development of Autolus Stevenage was made possible through key partnerships that have supported its delivery and long-term impact. UBS Asset Management provided critical investment, enabling the construction of a state-of-the-art manufacturing facility. Stevenage Borough Council played a pivotal role in facilitating planning approvals and integrating the development into the town’s regeneration strategy. CGT Catapult, a leader in advancing cell and gene therapy manufacturing, collaborated on process optimization, ensuring the facility meets the highest industry standards. Together, these partnerships have helped establish Autolus Stevenage as a pioneering centre for biopharmaceutical innovation.